Zulpiya Tursun, Ding Jianbing
The College of Pre-clinic, Xinjiang Medical University, Urumqi 830011, China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Oct;30(5):1136-40.
Recent studies show that the vector of recombinant Bacillus Calmette-Guérin (rBCG) has a series of advantages. With exogenous gene and vaccine in one inoculation, it can obtain strong and persistent immune response at one time so that BCG is considered as a kind of ideal vector for live recombinant vaccine. This review outlines the application of rBCG vaccine and its vector in infectious diseases caused by bacteria, viruses, other microorganisms and parasites.
